# Vision Infinitas

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vision-infinitas

- Industry: Consumer Products
- Headquarters: San Francisco, US
- Website: www.infinitas.vision
- Latest round: Seed (May 16, 2019)
- Investors on record: 2

## About

Vision Infinitas is a technology company dedicated to providing innovative AI solutions for diabetes management, enhancing health outcomes through personalized support and insights.Vision Infinitas specializes in diabetes management solutions, leveraging advanced artificial intelligence technology. Founded by Justin Lee and Sylvia Lee, the company is headquartered in San Francisco, US. In May 2019, Vision Infinitas raised seed funding from investors SOSV and HAX, marking a significant step in its growth trajectory. Justin Lee, also serving as CEO, has a history of entrepreneurial ventures, which helps steer the company's strategic direction.The company offers a cutting-edge AI solution named Vision, designed to assist individuals with diabetes. Vision utilizes continuous glucose monitoring (CGM) and insulin data to generate personalized responses to diabetes-related inquiries, operating 24/7 to address user needs. Key functionalities include guidance on basal rates, insulin-to-carb ratios, insulin sensitivity factors, as well as tailored nutrition and exercise advice. The product also features mental health support for effective diabetes management. Vision targets individuals with diabetes, caregivers, and healthcare professionals across North America, Europe, and selected regions in Asia.Vision Infinitas operates on a subscription-based revenue model, providing tailored diabetes management assistance via the Vision platform. Clients include individuals with diabetes, healthcare providers, and parents of children with diabetes, accessing the platform through a direct-to-consumer approach. Users benefit from ongoing personalized insights and recommendations, with subscription pricing varying according to service levels. Partnerships with healthcare organizations aim to integrate services within established practices, enhancing patient outcomes in diabetes care.Looking ahead, Vision Infinitas is focused on expanding its product offerings and market presence. Plans include the development of new features within the Vision platform, with specific release dates to be announced. The company aims to enter new markets in Asia and Europe by 2025, broadening its reach to support more individuals with diabetes. The seed funding raised in May 2019 will be allocated to enhance product development and expedite entry into these new regions, facilitating the company's long-term growth strategy.

## Funding rounds

- Seed, May 16, 2019 — SOSV, HAX

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- HAX — Seed